Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease-Reference-Cited by-同舟云学术

Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease

Published:2022-01-31 Issue:9 Volume:54 Page:2255-2261
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Costa Tiago Emanuel M.^ORCID,Lauar Julia C.^ORCID,Innecchi Mariana L. R.^ORCID,Coelho Venceslau A.^ORCID,Moysés Rosa M. A.^ORCID,Elias Rosilene M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-022-03116-5.pdf

Reference34 articles.

1. Miyaoka T, Mochizuki T, Takei T, Tsuchiya K, Nitta K (2014) Serum uric acid levels and long-term outcomes in chronic kidney disease. Heart Vessel 29(4):504–512. https://doi.org/10.1007/s00380-013-0396-0

2. Jeon HJ, Oh J, Shin DH (2019) Urate-lowering agents for asymptomatic hyperuricemia in stage 3–4 chronic kidney disease: controversial role of kidney function. PLoS ONE 14(6):e0218510. https://doi.org/10.1371/journal.pone.0218510

3. Sampson AL, Singer RF, Walters GD (2017) Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009460.pub2

4. Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M (2020) Group PS serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 382(26):2493–2503. https://doi.org/10.1056/NEJMoa1916624

5. Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW, Investigators C-FS (2020) Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 382(26):2504–2513. https://doi.org/10.1056/NEJMoa1915833

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Influence of Gout in Patients with Advanced Chronic Kidney Disease: Findings of a Large Retrospective Chart Review;Gout, Urate, and Crystal Deposition Disease;2024-03-21

2. Oxyberberrubine, a novel liver microsomes-mediated secondary metabolite of berberine, alleviates hyperuricemic nephropathy in mice;Phytomedicine;2023-01

3. Elevated Uric Acid Mediates the Effect of Obesity on Hypertension Development: A Causal Mediation Analysis in a Prospective Longitudinal Study;Clinical Epidemiology;2022-04